NCT01757730 Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
| NCT ID | NCT01757730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arunark Kolipaka |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2012-03 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2012-03 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Magnetic resonance elastography is a novel non-invasive MRI technique to obtain stiffness of soft tissues such as liver, heart, kidneys, etc. In this imaging technique a person is laid in an MR scanner and a paddle (plastic drum) is put on the area of interest to send sound vibration via a speaker placed outside the scan room which is connecting plastic drum via a plastic tube. These vibrations are scanned using MRI to estimate the stiffness of soft tissues such as liver, heart, kidneys, breast etc.
Eligibility Criteria
Inclusion Criteria: Any participant 18 years or older and are MR safe. Exclusion Criteria: That study participants will be excluded if they have any unapproved metal in their bodies, or if the volunteers are pregnant or possible of becoming pregnant. Also if the participants are claustrophobic.
Contact & Investigator
Arunark Kolipaka, PhD
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT01757730 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01757730 currently recruiting?
Yes, NCT01757730 is actively recruiting participants. Contact the research team at arunark.kolipaka@osumc.edu for enrollment information.
Where is the NCT01757730 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT01757730 clinical trial?
NCT01757730 is sponsored by Arunark Kolipaka. The principal investigator is Arunark Kolipaka, PhD at Ohio State University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.